Cardiovascular and Obstetric Delivery Complications in Pregnant Women With Valvular Heart Disease

被引:7
作者
Minhas, Anum S. [1 ,2 ,6 ]
Rahman, Faisal [1 ,6 ]
Gavin, Nicole [3 ,6 ]
Cedars, Ari [1 ,6 ]
Vaught, Arthur Jason [3 ,6 ]
Zakaria, Sammy [1 ,6 ]
Resar, Jon [1 ,6 ]
Schena, Stefano [4 ,6 ]
Schulman, Steven [1 ,6 ]
Zhao, Di [5 ,6 ]
Hays, Allison G. [1 ,6 ]
Michos, Erin D. [1 ,6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Maternal Fetal Med, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Div Cardiac Surg, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Sch Med, Baltimore, MD USA
[6] Johns Hopkins Univ, Baltimore, MD USA
关键词
LOW-DOSE ASPIRIN; OUTCOMES;
D O I
10.1016/j.amjcard.2021.07.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Women with valvular heart disease may be more likely to have adverse obstetric and cardiovascular complications during pregnancy. Most current recommendations focus on stenotic lesions with less guidance regarding regurgitant lesions. We aimed to compare adverse events at delivery for women with various stenotic and regurgitant valvular diseases. We used the 2016 to 2018 National Inpatient Sample data to compare demographics, comorbidities, and obstetric and cardiovascular complications during delivery hospitalizations. After adjusting for clinical and socioeconomic factors, logistic regression was performed to investigate associations between valvular disease and outcomes. Among > 11.2 million deliveries, 20,349 were in women with valvular disease. Women with valvular disease were older, had longer length of stays, and higher costs associated with delivery. They had higher prevalence of underlying cardiovascular comorbidities compared with women without valvular disease (hypertension: 5.1 vs 0.25%; pulmonary hypertension: 7.0 vs < 0.1%). At delivery, they had higher adjusted odds of obstetric events including preeclampsia and/or eclampsia (aOR 1.9 [1.8 to 2.2]) and intrapartum/postpartum hemorrhage (aOR 1.4 [1.2 to 1.6]), and cardiovascular events including peripartum cardiomyopathy (aOR 65 [53 to 78]), pulmonary edema (aOR 17 [13 to 22]), acute ischemic heart disease (aOR 19 [12 to 30]) and arrhythmias (aOR 22 [19 to 27]). There were valve lesion-specific differences in the magnitude of risk but both stenotic and regurgitant lesions were associated with elevated risk of cardiovascular complications. In conclusion, pregnant women with stenotic and regurgitant valvular disease have a greater burden of cardiovascular comorbidities and increased odds of obstetric and cardiovascular events at delivery. These women may benefit from specialized care from a Cardio-Obstetrics team. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [31] Performance of risk models predicting cardiac complications in pregnant women with congenital heart disease: a meta-analysis
    Wang, Tom Kai Ming
    Lowe, Boris
    Hlohovsky, Stephanie
    O'Donnell, Clare
    INTERNAL MEDICINE JOURNAL, 2020, 50 (04) : 481 - 484
  • [32] Evaluation of mode of birth in pregnant women with heart disease
    Petrus, Annelieke H. J.
    Jongert, Britt L.
    Kies, Philippine
    Sueters, Marieke
    Jongbloed, Monique R. M.
    Vliegen, Hubert W.
    Schalij, Martin J.
    van Lith, Jan
    van den Akker, Thomas
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 248 : 150 - 155
  • [33] Brain natriuretic peptide in pregnant women with heart disease
    Singh, Karanvir
    Sikka, Pooja
    Suri, Vanita
    Prasad, Rishikesh
    Khullar, Madhu
    Vijayvergiya, Rajesh
    OBSTETRIC MEDICINE, 2020, 13 (01) : 25 - 29
  • [34] Pregnancy and Delivery in Women With Congenital Heart Disease
    Warnes, Carole A.
    CIRCULATION JOURNAL, 2015, 79 (07) : 1416 - 1421
  • [35] Nonalcoholic steatohepatitis and obesity: influence of key risk factors on the development of obstetric and perinatal complications in pregnant women
    Bahnii, L., V
    Heriak, S. M.
    Bahnii, N., I
    ZAPOROZHYE MEDICAL JOURNAL, 2022, 24 (03) : 301 - 309
  • [36] Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease
    Burke, Kristin E.
    Haviland, Miriam J.
    Hacker, Michele R.
    Shainker, Scott A.
    Cheifetz, Adam S.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (05) : 721 - 726
  • [37] Valvular heart disease in pregnancy
    Windram, Jonathan D.
    Colman, Jack M.
    Wald, Rachel M.
    Udell, Jacob A.
    Siu, Samuel C.
    Silversides, Candice K.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2014, 28 (04) : 507 - 518
  • [38] The year in valvular heart disease
    Rahimtoola, Shahbudin H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (07) : 760 - 770
  • [39] Predictors of pregnancy complications in women with congenital heart disease
    Drenthen, Willem
    Boersma, Eric
    Balci, Ali
    Moons, Philip
    Roos-Hesselink, Jolien W.
    Mulder, Barbara J. M.
    Vliegen, Hubert W.
    van Dijk, Arie P. J.
    Voors, Adriaan A.
    Yap, Sing C.
    van Veldhuisen, Dirk J.
    Pieper, Petronella G.
    EUROPEAN HEART JOURNAL, 2010, 31 (17) : 2124 - 2132
  • [40] Valvular Heart Disease in Pregnancy
    Vasu, Sujethra
    Stergiopoulos, Kathleen
    HELLENIC JOURNAL OF CARDIOLOGY, 2009, 50 (06) : 498 - 510